IP Library Granted Patent US 9,376,698
Granted Patent B2
US 9,376,698 · App. 12/052,682 · Granted Jun 28, 2016

Mutant DNA polymerases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,376,698
App. No.
12/052,682
Granted
Jun 28, 2016
Kind
B2
Abstract

An isolated mutant Tfi DNA polymerase having a D144A point mutation. This polymerase may be used in methods including, but not limited to, nucleic acid synthesis, DNA sequencing, nucleic acid amplification and cDNA synthesis.

Claims (12)

1. An isolated mutant Tfi DNA polymerase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2 with a D→A point mutation at amino acid position 144 of SEQ ID NO:2 and an E→D point mutation at position 437 of SEQ ID NO:2.

2. The mutant Tfi DNA polymerase of claim 1 , wherein said mutant Tfi DNA polymerase is substantially reduced in 5′-3′ exonucleases activity (exo−) as compared to wild type Tfi DNA polymerase.

3. The mutant Tfi DNA polymerase of claim 2 , wherein said mutant Tfi DNA polymerase has about or less than 10% of the 5′-3′ exonuclease activity as compared to wild type Tfi DNA polymerase.

4. The mutant Tfi DNA polymerase of claim 1 , wherein said mutant Tfi DNA polymerase retains at least 5% of its polymerase activity after heating at 95° C. for 30 minutes as compared to wild type Tfi DNA polymerase.

5. The mutant Tfi DNA polymerase of claim 1 , wherein said mutant Tfi DNA polymerase has increased thermostability as compared to wild type Tfi DNA polymerase.

6. A composition comprising the mutant Tfi DNA polymerase of claim 1 .

7. The composition of claim 6 , further comprising a second Tfi DNA polymerase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2.

8. The composition of claim 7 , wherein said second Tfi DNA polymerase comprises the amino acid sequence of SEQ ID NO:2.

9. The composition of claim 7 , wherein said second Tfi DNA polymerase is exo+.

10. The composition of claim 7 , wherein said composition comprises a ratio of said mutant Tfi DNA polymerase to said second Tfi DNA polymerase selected from the group consisting of about 9:1, about 8:2, about 7:3, about 6:4, about 5:5, about 4:6, about 3:7, about 2:8, and about 1:9.

11. The composition of claim 9 , further comprising at least two components selected from the group consisting of a detergent, a buffer salt, at least one deoxynucleoside triphosphate (dNTP), and at least one dideoxynucleoside triphosphate (ddNTP).

12. The composition of claim 9 , wherein aid second Tfi DNA polymerase is thermostable.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2016
From: ZHENG, WEIDONG; LEE, JUN E.; POTTER, ROBERT JASON; MANDELMAN, DAVID
To: INVITROGEN CORPORATION
Reel/Frame 038340/0696 →
MERGER Recorded Apr 21, 2016
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 038341/0033 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →